Table 3.
Comparison of the REE between study groups before and after the intervention
| Variable | Omega-3 Group (n = 18) | Placebo Group (n = 18) | MD (95% CI), P |
|---|---|---|---|
| VO2 max (mL/kg/min) | |||
| Before | 264 (61.1) | 219 (57.9) | 44.9 (4.62, 85.2), 0.98b |
| After | 280 (66.6) | 225 (48.9) | 54.5, (14.9, 94.1), 0.01a |
| MD (95% CI), pa | −15.7 (−29.5, − 1.94), 0.03 | −6.17 (−23.3, 11.0), 0.46 | |
| REE (kcal/day) | |||
| Before | 1792 (311) | 1527 (404) | 265 (20.4, 509), 0.98b |
| After | 2012 (401) | 1557 (344) | 454 (201, 708), 0.01c |
| MD (95% CI), pa | − 220(−341, −98.3), 0.01 | −30.6(−181, 120), 0.67 | |
| REE% | |||
| Before | 99.5 (20.1) | 85.3 (22.2) | 14.1 (− 0.27, 28.5), 0.05b |
| After | 110 (23.1) | 87.3 (19.7) | 22.8 (8.27, 37.3), 0.01c |
| MD (95% CI), pa | −10.6(−16.1, −5.14), 0.01 | − 1.94(− 7.79, 3.90), 0.49 | |
Data are presented as Mean (standard deviation)
a p based on paired samples t-test
b p based on independent-samples t-test
c based on ANCOVA adjusted for baseline values
CI confidence of interval, MD mean differences, REE resting energy expenditure, VO2 max Maximal oxygen consumption